Medicine

Integrating liver endpoints in clinical trials of heart and renal health condition

.Nature Medication, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Standpoint requires incorporation of patients with MASLD and also size of liver results in cardio-- renal-- metabolic trials, when records recommend mechanistically possible benefits and also clinical protection-- and also summarizes considerations for test style as well as regulative approval.